Continuous positive airway pressure: new generations

Area of Science:

• Pulmonary Medicine
• Sleep Medicine
• Biomedical Engineering

Background:

• Automatic Positive Airway Pressure (APAP) devices represent an advancement in positive airway pressure therapy for Obstructive Sleep Apnea (OSA).
• These devices uniquely detect and adapt to upper airway resistance changes.
• The field is rapidly evolving, with data not always transferable between different APAP devices.

Purpose of the Study:

• To evaluate the diagnostic and therapeutic efficacy of APAP devices in managing Obstructive Sleep Apnea (OSA).
• To compare APAP therapy outcomes with conventional Continuous Positive Airway Pressure (CPAP).
• To explore the potential of APAP for unattended diagnosis and titration in OSA management.

Main Methods:

• Review of studies on APAP devices, focusing on supervised and carefully selected patient populations.
• Analysis of APAP's performance in diagnosing severe versus mild-moderate OSA.
• Comparison of APAP therapy outcomes (respiratory, sleep quality, oxygenation, sleepiness) against CPAP.

Main Results:

• APAP effectively diagnoses severe OSA, but reliability decreases for mild-moderate cases.
• Therapeutic outcomes with APAP are generally comparable to CPAP, often at lower mean pressures.
• Patient compliance and preference for APAP are similar to or better than CPAP, with no significant increase in side effects.

Conclusions:

• APAP is a viable therapeutic option for selected OSA patients, offering similar benefits to CPAP.
• Further research is needed to define optimal patient candidates for unattended APAP diagnosis and titration.
• While APAP devices are more costly, potential cost-effectiveness exists if unattended use is validated.